Resources

PATH lays out recommendations for the US Administration and Congress to accelerate progress toward a malaria-free world. By fully funding malaria programs, intensifying support for research and development, and leveraging US influence globally, the United States can take a decisive step toward eradicating malaria and a healthier future for all.

This brochure outlines PATH's work in Senegal. It describes our approach and outlines key areas of focus, including malaria elimination, strengthening health systems, responding to emerging health threats, improving reproductive health, and combatting noncommunicable diseases.

This poster demonstrates that the use of DHAp for malaria treatment was generally safe and well tolerated. A total of 687 adverse events (AEs) were reported (0.13% of participants, 0.24% of treatments). Four AEs were initially reported as serious adverse events, though three were later identified as not related to drug ingestion.

Real-time, accurate, and actionable data are critical for malaria elimination; using dashboards to visualize malaria data in Zambia is one possible solution to strengthen feedback loops to the most granular levels and motivate end users. To make dashboards matter, dashboards should be developed jointly with eventual end users and focus on tools for practical decision-making.

This poster, which focuses on data from Ethiopia and Senegal, shows that differences between DHIS2 and the facility source records are small and decreased from 2013 to 2014, suggesting that the system can provide accurate and timely information on malaria transmission intensity at the health-post level.